Bioceres Crop Solutions Corp. (BIOX) stock
BIOXNasdaqAgricultural ChemicalsFiscal year ends June 30
$0.23+0.02 (+8.48%)
Close on Nov 11, 2026Market cap $14.85MP/E –Yield –
Bioceres Crop Solutions cash
Cash and short-term investments held at the end of each period.
Bioceres Crop Solutions's cash was $11.24M at Jun 30, 2026. For fiscal 2026 it was $11.24M, down 65.6% from the year before. The highest annual figure on record is $48.13M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $11.24M | -65.6% |
| FY2025 | Jun 30, 2025 | $32.70M | -26.5% |
| FY2024 | Jun 30, 2024 | $44.47M | -7.6% |
| FY2023 | Jun 30, 2023 | $48.13M | +43.8% |
| FY2022 | Jun 30, 2022 | $33.48M | -7.1% |
| FY2021 | Jun 30, 2021 | $36.05M | -15.2% |
| FY2020 | Jun 30, 2020 | $42.52M | +1132.2% |
| FY2019 | Jun 30, 2019 | $3.45M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $11.24M | -70.8% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $11.06M | -62.1% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $15.51M | -52.0% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $32.70M | -26.5% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $38.46M | +135.0% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $29.18M | +19.6% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $32.28M | +13.8% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $44.47M | -7.6% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $16.36M | -71.7% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $24.40M | -64.4% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $28.37M | -15.2% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $48.13M | +32.3% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $57.74M | +60.2% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $68.55M | +258.3% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $33.48M | -21.3% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $36.37M | +244.1% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $36.05M | +944.6% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $19.13M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $42.52M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $10.57M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $3.45M | – |
See a number that looks wrong?